back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
||
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-250,000 vol |
0 | |
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-150,000 vol |
250,000 | |
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+250,000 vol $0.20 each |
||
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,500
+250,000 vol $0.05 each |
2,611,559 | |
| Filed 2017-10-17 Tx date 2017-10-17 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$30,000
+150,000 vol $0.20 each |
2,361,559 | |
| Filed 2017-01-25 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
400,000 | |
| Filed 2017-01-06 Tx date 2017-01-03 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+180,000 vol |
2,211,559 | |
| Filed 2017-01-06 Tx date 2017-01-03 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-180,000 vol |
2,031,559 | |
| Filed 2016-10-25 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-2,211,559 vol |
0 | |
| Filed 2016-10-25 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+2,211,559 vol |
2,211,559 | |
| Filed 2016-10-24 Tx date 2016-09-24 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-49,800
-166,000 vol $0.30 each |
250,000 | |
| Filed 2016-10-24 Tx date 2016-10-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Palm American Investments Inc. (Control or Direction)
|
Common Shares
97 - Other
|
-196,771 vol |
0 | |
| Filed 2015-12-24 Tx date 2015-12-23 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-19,500 vol |
2,192,059 | |
| Filed 2015-12-24 Tx date 2015-12-23 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+19,500 vol |
2,211,559 | |
| Filed 2015-08-14 Tx date 2015-08-13 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,350
-3,000 vol $0.45 each |
2,211,559 | |
| Filed 2015-08-14 Tx date 2015-08-12 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-800.00
-2,000 vol $0.40 each |
2,214,559 | |
| Filed 2015-07-31 Tx date 2015-07-29 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,850
-5,000 vol $0.37 each |
2,216,559 | |
| Filed 2015-07-15 Tx date 2015-07-14 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,600
-5,000 vol $0.32 each |
2,221,559 | |
| Filed 2015-05-22 Tx date 2015-05-21 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,400
-5,000 vol $0.28 each |
2,226,559 | |
| Filed 2015-05-13 Tx date 2015-05-13 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-675.00
-2,500 vol $0.27 each |
2,231,559 | |
| Filed 2015-05-11 Tx date 2015-05-08 |
$BCC
The Canadian Bioceutical Corporation |
Bloovol, Marilyn
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-130.00
-500 vol $0.26 each |
2,234,059 |